🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

$1.4 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying

Published 21/07/2022, 11:39
© Reuters.  $1.4 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying
MEDP
-
TCDAQ
-
RKT
-

Although US stocks closed higher on Wednesday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Tricida

  • The Trade: Tricida, Inc. (NASDAQ: TCDA) 10% owner Nimish Shah acquired a total of 150,000 shares at an average price of $9.18. To acquire these shares, it cost around $1.38 million.
  • What’s Happening: The company’s stock gained around 8% over the past six months.
  • What Tricida Does: Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract.
Medpace Holdings
  • The Trade: Medpace Holdings, Inc. (NASDAQ: MEDP) CEO August J Troendle acquired a total of 8,330 shares at an average price of $145.00. To acquire these shares, it cost around $1.21 million.
  • What’s Happening: Medpace Holdings is expected to report its Q2 financial results after the market close on Monday, July 25, 2022.
  • What Medpace Holdings Does: Medpace Holdings Inc is a clinical contract research organization.
Don’t forget to check out our premarket coverage here .

Also check this: Investor Fear Eases Further, Here's Why

Rocket Companies

  • The Trade: Rocket Companies, Inc. (NYSE: RKT) CEO Jay Farner bought a total of 64,900 shares at an average price of $9.24. To acquire these shares, it cost around $599.37 thousand.
  • What’s Happening: Wells Fargo (NYSE:WFC) recently upgraded the stock from Equal-Weight to Overweight and announced a $10 price target.
  • What Rocket Companies Does: Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.